Market revenue in 2023 | USD 2,269.1 million |
Market revenue in 2030 | USD 4,009.7 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Biobanking equipment |
Fastest growing segment | LIMS |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biobanking Equipment, Biobanking Consumables, LIMS |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Qiagen NV, Booz Allen Hamilton Holding Corp Class A, Tecan Group AG, Danaher Corp, Becton Dickinson & Co, Taylor-Wharton, Charles River Laboratories International Inc, Lonza Group Ltd, STEMCELL Technologies, PromoCell GmbH |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biobank market will help companies and investors design strategic landscapes.
Biobanking equipment was the largest segment with a revenue share of 77.01% in 2023. Horizon Databook has segmented the Sweden biobank market based on biobanking equipment, biobanking consumables, lims covering the revenue growth of each sub-segment from 2018 to 2030.
Sweden consists of over 450 registered biobanks containing around 160 million samples. The biobanks market in this country is expected to benefit from the collaborative initiatives undertaken by key entities. For instance.
in January 2018, Biobank Sweden, the country’s new national biobanking infrastructure was set up to aid in the national harmonization of biobanking operations. In addition, strong government support in the country is expected to propel advancements in biobanking applications in Sweden.
For instance, the Swedish government has planned to replace the current Biobanks Act with new legislation by July 2023. The new act would promote research activities in the healthcare sector and lead to better protection of donor data.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden biobank market , including forecasts for subscribers. This country databook contains high-level insights into Sweden biobank market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account